Aardvark Therapeutics, Inc.
AARD
$4.11
-$0.43-9.47%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -21.59M | -17.60M | -16.32M | -14.37M | -9.31M |
| Total Depreciation and Amortization | 11.00K | 10.00K | 10.00K | 11.00K | 5.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.99M | 1.45M | 1.18M | 127.00K | 274.00K |
| Change in Net Operating Assets | 723.00K | -673.00K | -999.00K | 4.39M | -2.36M |
| Cash from Operations | -18.87M | -16.81M | -16.13M | -9.84M | -11.39M |
| Capital Expenditure | -- | 0.00 | -4.00K | -91.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 34.25M | 24.30M | 29.25M | 9.50M | -112.62M |
| Cash from Investing | 34.25M | 24.30M | 29.25M | 9.41M | -112.62M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.00K | 274.00K | 171.00K | 6.00K | 91.19M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | -77.00K | -2.31M |
| Cash from Financing | 4.00K | 274.00K | 171.00K | -71.00K | 88.88M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15.39M | 7.77M | 13.29M | -506.00K | -35.14M |